418 related articles for article (PubMed ID: 30742277)
1. The Impact of Comorbidities on the Pharmacological Management of Type 2 Diabetes Mellitus.
Hussain S; Chowdhury TA
Drugs; 2019 Feb; 79(3):231-242. PubMed ID: 30742277
[TBL] [Abstract][Full Text] [Related]
2. Evolving Concepts of Type 2 Diabetes Management.
Abushamat LA; Reusch JEB
Med Clin North Am; 2021 Nov; 105(6):955-966. PubMed ID: 34688420
[TBL] [Abstract][Full Text] [Related]
3. Overview of Data Concerning the Safe Use of Antihyperglycemic Medications in Type 2 Diabetes Mellitus and Chronic Kidney Disease.
Roussel R; Lorraine J; Rodriguez A; Salaun-Martin C
Adv Ther; 2015 Nov; 32(11):1029-64. PubMed ID: 26581749
[TBL] [Abstract][Full Text] [Related]
4. Newer anti-diabetic therapies with low hypoglycemic risk-potential advantages for frail older people.
Emmerton D; Abdelhafiz A
Hosp Pract (1995); 2021 Aug; 49(3):164-175. PubMed ID: 33729898
[TBL] [Abstract][Full Text] [Related]
5. Cardio-renal protection in older people with diabetes with frailty and medical comorbidities - A focus on the new hypoglycaemic therapy.
Abdelhafiz AH; Sinclair AJ
J Diabetes Complications; 2020 Sep; 34(9):107639. PubMed ID: 32595017
[TBL] [Abstract][Full Text] [Related]
6. Posttransplant Diabetes Mellitus: Recent Developments in Pharmacological Management of Hyperglycemia.
Munoz Pena JM; Cusi K
J Clin Endocrinol Metab; 2023 Dec; 109(1):e1-e11. PubMed ID: 37410930
[TBL] [Abstract][Full Text] [Related]
7. How to fight obesity with antidiabetic drugs: targeting gut or kidney?
Baretić M; Troskot R
Minerva Endocrinol; 2015 Mar; 40(1):71-83. PubMed ID: 25366984
[TBL] [Abstract][Full Text] [Related]
8. Impact of Current and Emerging Glucose-Lowering Drugs on Body Weight in Type 2 Diabetes.
Lau DC; Teoh H
Can J Diabetes; 2015 Dec; 39 Suppl 5():S148-54. PubMed ID: 26654858
[TBL] [Abstract][Full Text] [Related]
9. Management of type 2 diabetes in chronic kidney disease.
Triozzi JL; Parker Gregg L; Virani SS; Navaneethan SD
BMJ Open Diabetes Res Care; 2021 Jul; 9(1):. PubMed ID: 34312158
[TBL] [Abstract][Full Text] [Related]
10. The nephrological perspective on SGLT-2 inhibitors in type 1 diabetes.
Gillard P; Schnell O; Groop PH
Diabetes Res Clin Pract; 2020 Dec; 170():108462. PubMed ID: 32971152
[TBL] [Abstract][Full Text] [Related]
11. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL; Figgitt DP
Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
[TBL] [Abstract][Full Text] [Related]
12. Management of hypoglycemia in older adults with type 2 diabetes.
Freeman J
Postgrad Med; 2019 May; 131(4):241-250. PubMed ID: 30724638
[TBL] [Abstract][Full Text] [Related]
13. Pharmacologic Management of Type 2 Diabetes Mellitus: Available Therapies.
Thrasher J
Am J Med; 2017 Jun; 130(6S):S4-S17. PubMed ID: 28526182
[TBL] [Abstract][Full Text] [Related]
14. Diabetes in the older patient: heterogeneity requires individualisation of therapeutic strategies.
Schernthaner G; Schernthaner-Reiter MH
Diabetologia; 2018 Jul; 61(7):1503-1516. PubMed ID: 29417185
[TBL] [Abstract][Full Text] [Related]
15. Use of SGLT-2 Inhibitors in Patients with Type 2 Diabetes Mellitus and Abdominal Obesity: An Asian Perspective and Expert Recommendations.
Sheu WHH; Chan SP; Matawaran BJ; Deerochanawong C; Mithal A; Chan J; Suastika K; Khoo CM; Nguyen HM; Linong J; Luk A; Yoon KH
Diabetes Metab J; 2020 Feb; 44(1):11-32. PubMed ID: 32097996
[TBL] [Abstract][Full Text] [Related]
16. Clinical considerations when adding a sodium-glucose co-transporter-2 inhibitor to insulin therapy in patients with diabetes mellitus.
Tan K; Chow WS; Leung J; Ho A; Ozaki R; Kam G; Li J; Choi CH; Tsang MW; Chan N; Lee KK; Chan KW
Hong Kong Med J; 2019 Aug; 25(4):312-319. PubMed ID: 31416990
[No Abstract] [Full Text] [Related]
17. Pharmacologic Management of Type 2 Diabetes Mellitus: Available Therapies.
Thrasher J
Am J Cardiol; 2017 Jul; 120(1S):S4-S16. PubMed ID: 28606343
[TBL] [Abstract][Full Text] [Related]
18. Non-insulin anti-diabetic drugs: An update on pharmacological interactions.
Ruscica M; Baldessin L; Boccia D; Racagni G; Mitro N
Pharmacol Res; 2017 Jan; 115():14-24. PubMed ID: 27838511
[TBL] [Abstract][Full Text] [Related]
19. Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
Davies MJ; D'Alessio DA; Fradkin J; Kernan WN; Mathieu C; Mingrone G; Rossing P; Tsapas A; Wexler DJ; Buse JB
Diabetologia; 2018 Dec; 61(12):2461-2498. PubMed ID: 30288571
[TBL] [Abstract][Full Text] [Related]
20. The Potential Role of SGLT2 Inhibitors in the Treatment of Type 1 Diabetes Mellitus.
Fattah H; Vallon V
Drugs; 2018 May; 78(7):717-726. PubMed ID: 29663292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
